Page last updated: 2024-11-06

2-bromobenzaldehyde

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Bromobenzaldehyde is a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its synthesis typically involves the bromination of benzaldehyde in the presence of a suitable catalyst. 2-bromobenzaldehyde is a versatile building block in organic synthesis, often used to introduce the formyl group (CHO) into complex molecules. It is also known to exhibit biological activity, including antifungal and antibacterial properties, making it an important subject of study in medicinal chemistry.'

2-bromobenzaldehyde: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID81129
CHEMBL ID3236916
SCHEMBL ID95292
MeSH IDM000613741

Synonyms (39)

Synonym
o-bromobenzaldehyde
benzaldehyde, o-bromo-
nsc60390
nsc-60390
inchi=1/c7h5bro/c8-7-4-2-1-3-6(7)5-9/h1-5
benzaldehyde, 2-bromo-
2-bromobenzaldehyde
6630-33-7
2-bromobenzaldehyde, 98%
B-5780
AC-4962
B0836
AKOS000120460
einecs 229-622-2
nsc 60390
unii-etk6fj5fu9
etk6fj5fu9 ,
2-formylbromobenzene
FT-0623222
CHEMBL3236916
SCHEMBL95292
AM81350
DTXSID8064430
2-bromo-benzaldehyde
bromobenzaldehyde
2-bromo benzaldehyde
ortho-bromobenzaldehyde
o-bromo-benzaldehyde
bromo benzaldehyde
STR03087
PS-8508
mfcd00003300
F2190-0589
CS-D1759
SY001671
Q33859440
EN300-20472
2-brombenzaldehyde
Z104478338
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1127996Toxicity in fluoroquinolone-resistant Staphylococcus aureus 1199B expressing NorA after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1127992Inhibition of NorA in fluoroquinolone-resistant Staphylococcus aureus 1199B assessed as potentiation of 4 ug/ml of ciprofloxacin MIC at 100 ug/ml after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1544945Inhibition of NO711 binding to mouse GAT1 expressed in HEK293 cell membranes assessed as residual binding at 1 uM incubated for 4 hrs in presence of NO711 by LC-ESI-MS/MS analysis relative to control2019Bioorganic & medicinal chemistry, 07-01, Volume: 27, Issue:13
Application of the concept of oxime library screening by mass spectrometry (MS) binding assays to pyrrolidine-3-carboxylic acid derivatives as potential inhibitors of γ-aminobutyric acid transporter 1 (GAT1).
AID1656235Cytotoxicity against mouse B16F10 cells assessed as reduction in cell viability2019European journal of medicinal chemistry, Feb-15, Volume: 164Green recipes to quinoline: A review.
AID1127995Toxicity in Staphylococcus aureus ATCC 25923 after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 44.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index44.59 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index60.75 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (44.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]